Free Trial

Xilio Therapeutics (XLO) SEC Filings & 10K Form

Xilio Therapeutics logo
$0.71 0.00 (-0.34%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$0.73 +0.02 (+3.09%)
As of 08:25 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Xilio Therapeutics SEC Filings

DateFilerForm TypeView
03/11/2025
8:30 AM
Xilio Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/11/2025
7:50 AM
Xilio Therapeutics (Filer)
Form 424B5
03/11/2025
7:54 AM
Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2025
7:43 AM
Xilio Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2025
7:15 AM
Xilio Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2025
6:39 AM
Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
6:36 AM
Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
4:09 PM
Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
3:15 PM
GILEAD SCIENCES, INC. (Filed by)
Xilio Therapeutics (Subject)
Form SCHEDULE 13G/A
12/19/2024
3:19 PM
GILEAD SCIENCES, INC. (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
6:45 AM
Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:44 PM
Bain Capital Life Sciences Fund II, L.P. (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G/A
11/12/2024
3:50 PM
Rock Springs Capital Management LP (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G/A
11/12/2024
9:40 AM
FMR LLC (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G/A
11/07/2024
8:25 AM
Xilio Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
8:20 AM
Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
8:36 PM
GKCC, LLC (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G
09/27/2024
8:00 PM
Chudnovsky Yekaterina (Reporting)
GKCC, LLC (Reporting)
Xilio Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/08/2024
6:45 AM
Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:51 AM
Xilio Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
7:00 PM
Frankenfield Christopher James (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
6:46 AM
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G/A
06/17/2024
3:30 PM
Curran Daniel J. (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:30 PM
Clancy Paul J (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:30 PM
Rossi Christina (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:30 PM
ROSS ROBERT W. (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:30 PM
Bonstein Sara (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:30 PM
Xilio Therapeutics (Issuer)
Xu Yuan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
7:09 AM
Xilio Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
6:45 AM
Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
11:15 PM
Xilio Therapeutics (Filer)
Form EFFECT
04/30/2024
4:09 PM
Xilio Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:XLO) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners